Circulating Levels of Urokinase-Type Plasminogen Activator Receptor and D-Dimer in Patients With Hematological Malignancies. [electronic resource]
- Clinical lymphoma, myeloma & leukemia Oct 2015
- 621-6 p. digital
Publication Type: Journal Article
2152-2669
10.1016/j.clml.2015.07.632 doi
Adult Aged Aged, 80 and over Biomarkers, Tumor--blood Case-Control Studies Cross-Sectional Studies Female Fibrin Fibrinogen Degradation Products--metabolism Humans Lymphoma--blood Male Middle Aged Receptors, Urokinase Plasminogen Activator--blood Survival Analysis Treatment Outcome